These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38920184)

  • 1. Screening of nasopharyngeal cancer in high-risk familial cohort: A practical approach using a screening algorithm.
    Wee JJ; Jang IJH; Teo NWY; Loh ICY; Charn TC; Eu DKC; Tsang RKY; Lim MY; Huang LM; Mok PKH; Toh ST; Lim CM
    Ann Acad Med Singap; 2024 Apr; 53(4):268-271. PubMed ID: 38920184
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Tay JK; Siow CH; Goh HL; Lim CM; Hsu PP; Chan SH; Loh KS
    Int J Cancer; 2020 May; 146(10):2923-2931. PubMed ID: 31705522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.
    Chen H; Chen S; Lu J; Wang X; Li J; Li L; Fu J; Scheper T; Meyer W; Peng YH; Liu W
    Cancer Prev Res (Phila); 2017 Sep; 10(9):542-550. PubMed ID: 28754665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
    Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
    Chan KCA; Woo JKS; King A; Zee BCY; Lam WKJ; Chan SL; Chu SWI; Mak C; Tse IOL; Leung SYM; Chan G; Hui EP; Ma BBY; Chiu RWK; Leung SF; van Hasselt AC; Chan ATC; Lo YMD
    N Engl J Med; 2017 Aug; 377(6):513-522. PubMed ID: 28792880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness evaluation of seven screening strategies for nasopharyngeal carcinoma].
    Rao DP; Liu Q; Cao SM
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):549-53. PubMed ID: 22967476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.
    Rao DP; Gu J; Meng XH; Zhang Q; Fu MQ; Liu Y; Chen F; Cao SM; Hong MH; Liu Q
    J Int Med Res; 2012; 40(2):525-36. PubMed ID: 22613413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
    Chen Y; Zhao W; Lin L; Xiao X; Zhou X; Ming H; Huang T; Liao J; Li Y; Zeng X; Huang G; Ye W; Zhang Z
    PLoS One; 2015; 10(7):e0132669. PubMed ID: 26151639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".
    Liu Z; Ye W; Zeng YX; Cao SM
    Am J Epidemiol; 2013 Feb; 177(3):254-5. PubMed ID: 23255782
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.
    Liu Z; Ji MF; Huang QH; Fang F; Liu Q; Jia WH; Guo X; Xie SH; Chen F; Liu Y; Mo HY; Liu WL; Yu YL; Cheng WM; Yang YY; Wu BH; Wei KR; Ling W; Lin X; Lin EH; Ye W; Hong MH; Zeng YX; Cao SM
    Am J Epidemiol; 2013 Feb; 177(3):242-50. PubMed ID: 23255783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
    Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia.
    Baizig NM; Morand P; Seigneurin JM; Boussen H; Fourati A; Gritli S; Oueslati Z; Touati S; Gamoudi A; Ben Abdallah M; El May M; El May A
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1005-11. PubMed ID: 21805179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.
    King AD; Ai QYH; Lam WKJ; Tse IOL; So TY; Wong LM; Tsang JYM; Leung HS; Zee BCY; Hui EP; Ma BBY; Vlantis AC; van Hasselt AC; Chan ATC; Woo JKS; Chan KCA
    J Natl Cancer Inst; 2024 May; 116(5):665-672. PubMed ID: 38171488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of nasopharyngeal carcinoma: detecting LMP-1 and EBNA by nasopharyngeal swab.
    Hao SP; Tsang NM; Chang KP; Ueng SH
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):651-4. PubMed ID: 15523443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
    Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
    Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.
    Lam WKJ; King AD; Miller JA; Liu Z; Yu KJ; Chua MLK; Ma BBY; Chen MY; Pinsky BA; Lou PJ; Woo JKS; Hsu WL; Simon J; Doolan DL; Waterboer T; Hui EP; Li H; Tsang RK; Wong KCW; Goh JP; Vlantis AC; Ai QY; Wong LM; Abdullah V; Lin JC; Chen CJ; Pfeiffer RM; Le QT; Lee AWM; Ji M; Cao S; Ma J; Chan ATC; Chan KCA; Hildesheim A
    J Natl Cancer Inst; 2023 Apr; 115(4):355-364. PubMed ID: 36723440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.
    Choi CW; Lee MC; Ng WT; Law LY; Yau TK; Lee AW
    Fam Cancer; 2011 Mar; 10(1):133-9. PubMed ID: 21052850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination.
    Ji MF; Yu YL; Cheng WM; Zong YS; Ng PS; Chua DT; Ng MH
    Chin J Cancer; 2011 Feb; 30(2):120-3. PubMed ID: 21272444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.